In this free webinar, learn about the development of new generation vectors and effective process improvements to increase the utility of CHO DG44 as a cell line development platform. The featured speaker will discuss the challenges faced while using the dihydrofolate reductase (DHFR)-deficient CHO DG44 platform. Attendees will learn about driving better titers and shorter timelines with a robust and scalable CHO DG44 platform.
TORONTO, Sept. 15, 2022 /PRNewswire-PRWeb/ -- Chinese hamster ovary (CHO) cells have been the cell line of choice for producing most biotherapeutics. The dihydrofolate reductase (DHFR)-deficient CHO DG44 is a well characterized cell line that exhibits long-term stability and is a universally accepted platform in the industry for producing diverse monoclonal antibodies and proteins. However, there are different challenges faced by the biopharmaceutical industry while using the CHO DG44 platform, including prolonged timelines from gene synthesis to production of a research cell bank and the low product titers. Improved process design as well as vector modifications can help address both limitations to improve titers and to achieve faster results for expediting therapeutic objectives.
In the upcoming webinar, the featured speaker will lead a discussion on the development of new generation vectors and effective process improvements to increase the utility of CHO DG44 as a cell line development platform.
Register to learn about driving better titers and shorter timelines with a robust and scalable CHO DG44 platform.
Join Dr. Sufia Karim, Director, Cell Line Development, Aragen Life Sciences, for the live webinar on Thursday, October 6, 2022, at 11am EDT (4pm BST/UK).
For more information, or to register for this event, visit Driving Better Titers and Shorter Timelines with a Robust and Scalable CHO DG44 Platform.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]
SOURCE Xtalks
Share this article